Shelter Pharma Ltd.
Shelter Pharma Ltd. Fundamental Analysis
Shelter Pharma Ltd. (SHELTER.BO) shows moderate financial fundamentals with a PE ratio of 7.60, profit margin of 14.16%, and ROE of 11.80%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze SHELTER.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakSHELTER.BO struggles to generate sufficient returns from assets.
Valuation Score
ExcellentSHELTER.BO trades at attractive valuation levels.
Growth Score
ModerateSHELTER.BO shows steady but slowing expansion.
Financial Health Score
ExcellentSHELTER.BO maintains a strong and stable balance sheet.
Profitability Score
WeakSHELTER.BO struggles to sustain strong margins.
Key Financial Metrics
Is SHELTER.BO Expensive or Cheap?
P/E Ratio
SHELTER.BO trades at 7.60 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SHELTER.BO's PEG of 1.75 indicates fair valuation.
Price to Book
The market values Shelter Pharma Ltd. at 0.68 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.99 times EBITDA. This is generally considered low.
How Well Does SHELTER.BO Make Money?
Net Profit Margin
For every $100 in sales, Shelter Pharma Ltd. keeps $14.16 as profit after all expenses.
Operating Margin
Core operations generate 22.83 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.80 in profit for every $100 of shareholder equity.
ROA
Shelter Pharma Ltd. generates $8.18 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Shelter Pharma Ltd. produces operating cash flow of $45.58M, showing steady but balanced cash generation.
Free Cash Flow
Shelter Pharma Ltd. produces free cash flow of $23.50M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $2.03 in free cash annually.
FCF Yield
SHELTER.BO converts 5.65% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
7.60
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.75
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.68
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.08
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
7.95
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How SHELTER.BO Stacks Against Its Sector Peers
| Metric | SHELTER.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 7.60 | 29.78 | Better (Cheaper) |
| ROE | 11.80% | 792.00% | Weak |
| Net Margin | 14.16% | -24634.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.25 | Strong (Low Leverage) |
| Current Ratio | 7.95 | 4.60 | Strong Liquidity |
| ROA | 8.18% | -18106.00% (disorted) | Weak |
SHELTER.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Shelter Pharma Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation